JPMorgan Dad Turns Biotech CEO in Disease Quest

Feb. 20 (Bloomberg) -- Ilan Ganot, founder of Solid Ventures, talks about his decision to leave his career to create the biotechnology company after his son, Eytani, was diagnosed with Duchenne muscular dystrophy, a fatal genetic disease. Ganot, a former hedge fund specialist at JPMorgan Chase & Co., now aims to tackle the disease with a strategy he calls condition focus, a sole concentration on DMD. (Source: Bloomberg)

U.K.'s Abbott: Military Cannot Be Only Anti-Terror Weapon
47:32 - U.K. Shadow Home Secretary Diane Abbott discusses Labour Party concerns about the U.K.'s approach to the war on terror and looks at the nation's upcoming election on June 8 and the impact of Brexit. She speaks with Bloomberg's Francine Lacqua on "Bloomberg News." (Source: Bloomberg)
  • Terra Firma's Hands Says Britain Lost Control of Economy
  • Energy Aspects' Sen Sees OPEC Cutting Exports in 3Q
  • American Health Care Act: Charlie Rose